Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.
Multisystemic proteinopathy
Muscle MRI
VCP myopathy
Valosin
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
06
05
2023
accepted:
01
07
2023
revised:
29
06
2023
medline:
9
11
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
ppublish
Résumé
The diagnosis of patients with mutations in the VCP gene can be complicated due to their broad phenotypic spectrum including myopathy, motor neuron disease and peripheral neuropathy. Muscle MRI guides the diagnosis in neuromuscular diseases (NMDs); however, comprehensive muscle MRI features for VCP patients have not been reported so far. We collected muscle MRIs of 80 of the 255 patients who participated in the "VCP International Study" and reviewed the T1-weighted (T1w) and short tau inversion recovery (STIR) sequences. We identified a series of potential diagnostic MRI based characteristics useful for the diagnosis of VCP disease and validated them in 1089 MRIs from patients with other genetically confirmed NMDs. Fat replacement of at least one muscle was identified in all symptomatic patients. The most common finding was the existence of patchy areas of fat replacement. Although there was a wide variability of muscles affected, we observed a common pattern characterized by the involvement of periscapular, paraspinal, gluteal and quadriceps muscles. STIR signal was enhanced in 67% of the patients, either in the muscle itself or in the surrounding fascia. We identified 10 diagnostic characteristics based on the pattern identified that allowed us to distinguish VCP disease from other neuromuscular diseases with high accuracy. Patients with mutations in the VCP gene had common features on muscle MRI that are helpful for diagnosis purposes, including the presence of patchy fat replacement and a prominent involvement of the periscapular, paraspinal, abdominal and thigh muscles.
Sections du résumé
BACKGROUND
BACKGROUND
The diagnosis of patients with mutations in the VCP gene can be complicated due to their broad phenotypic spectrum including myopathy, motor neuron disease and peripheral neuropathy. Muscle MRI guides the diagnosis in neuromuscular diseases (NMDs); however, comprehensive muscle MRI features for VCP patients have not been reported so far.
METHODS
METHODS
We collected muscle MRIs of 80 of the 255 patients who participated in the "VCP International Study" and reviewed the T1-weighted (T1w) and short tau inversion recovery (STIR) sequences. We identified a series of potential diagnostic MRI based characteristics useful for the diagnosis of VCP disease and validated them in 1089 MRIs from patients with other genetically confirmed NMDs.
RESULTS
RESULTS
Fat replacement of at least one muscle was identified in all symptomatic patients. The most common finding was the existence of patchy areas of fat replacement. Although there was a wide variability of muscles affected, we observed a common pattern characterized by the involvement of periscapular, paraspinal, gluteal and quadriceps muscles. STIR signal was enhanced in 67% of the patients, either in the muscle itself or in the surrounding fascia. We identified 10 diagnostic characteristics based on the pattern identified that allowed us to distinguish VCP disease from other neuromuscular diseases with high accuracy.
CONCLUSIONS
CONCLUSIONS
Patients with mutations in the VCP gene had common features on muscle MRI that are helpful for diagnosis purposes, including the presence of patchy fat replacement and a prominent involvement of the periscapular, paraspinal, abdominal and thigh muscles.
Identifiants
pubmed: 37603075
doi: 10.1007/s00415-023-11862-4
pii: 10.1007/s00415-023-11862-4
pmc: PMC10632218
doi:
Substances chimiques
Valosin Containing Protein
EC 3.6.4.6
VCP protein, human
EC 3.6.4.6
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5849-5865Subventions
Organisme : Academy of Medical Sciences
ID : Professorship Scheme APR4/1007
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/W019086/1
Pays : United Kingdom
Informations de copyright
© 2023. The Author(s).
Références
Skeletal Radiol. 2007 Jul;36(7):609-26
pubmed: 17410356
Int J Mol Sci. 2020 May 28;21(11):
pubmed: 32481679
J Neurol. 2020 Jan;267(1):45-56
pubmed: 31555977
Neuromuscul Disord. 2009 May;19(5):308-15
pubmed: 19380227
Neuromuscul Disord. 2019 Nov;29(11):827-841
pubmed: 31727541
J Neurol Neurosurg Psychiatry. 2018 Jan;89(1):72-77
pubmed: 28889091
JAMA Neurol. 2016 Sep 1;73(9):1105-14
pubmed: 27400454
Neurology. 2012 Nov 27;79(22):2201-8
pubmed: 23152587
Acta Myol. 2015 Dec;34(2-3):95-108
pubmed: 27199536
Ann Neurol. 2016 May;79(5):854-864
pubmed: 26994363
Front Neurol. 2019 Feb 11;10:78
pubmed: 30804884
Genet Med. 2000 Jul-Aug;2(4):232-41
pubmed: 11252708
Orphanet J Rare Dis. 2022 Jan 29;17(1):23
pubmed: 35093159
Neuromuscul Disord. 2011 Aug;21(8):551-5
pubmed: 21684747
AJR Am J Roentgenol. 2011 Jun;196(6 Suppl):S64-75
pubmed: 21606236
Mol Genet Genomic Med. 2023 Jul;11(7):e2176
pubmed: 37002192
Neuromuscul Disord. 2020 Mar;30(3):232-235
pubmed: 32165109
PLoS One. 2013 Aug 14;8(8):e70993
pubmed: 23967145
Acta Myol. 2017 Dec 01;36(4):203-206
pubmed: 29770363
Muscle Nerve. 2021 Apr;63(4):442-454
pubmed: 33145792
Mol Brain. 2016 Mar 22;9:31
pubmed: 27000202
Neuron. 2010 Dec 9;68(5):857-64
pubmed: 21145000
Nat Genet. 2004 Apr;36(4):377-81
pubmed: 15034582
Eur J Radiol. 2022 Oct;155:110475
pubmed: 35998441
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):680-1
pubmed: 26105173
Neuromuscul Disord. 2021 Aug;31(8):701-705
pubmed: 34244020
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1071-1081
pubmed: 29735511
Curr Opin Neurol. 2020 Oct;33(5):611-620
pubmed: 32796278
PLoS One. 2014 Jun 16;9(6):e100292
pubmed: 24932477
Neuromuscul Disord. 2016 Aug;26(8):535-47
pubmed: 27312024
J Neurol Neurosurg Psychiatry. 2022 Jul 27;:
pubmed: 35896379
Neuromuscul Disord. 2020 Nov;30(11):938-947
pubmed: 33004285
Neuromuscul Disord. 2022 Feb;32(2):142-149
pubmed: 35033413
Ann Neurol. 2020 Oct;88(4):669-681
pubmed: 32495452
Radiographics. 2002 Sep-Oct;22(5):1191-216
pubmed: 12235348
J Med Genet. 2012 Jan;49(1):41-6
pubmed: 21984748
BMC Neurol. 2022 Nov 3;22(1):406
pubmed: 36329418
Neurology. 2020 Mar 10;94(10):e1094-e1102
pubmed: 32029545
Muscle Nerve. 2015 Dec;52(6):956-62
pubmed: 25808807
Brain. 2014 Nov;137(Pt 11):2897-902
pubmed: 25125609
Proteomics Clin Appl. 2009 Apr;3(4):486-97
pubmed: 21136973
Inflammation. 2017 Feb;40(1):21-41
pubmed: 27730320
Brain. 2012 Dec;135(Pt 12):e223; author reply e224
pubmed: 22991237
Eur J Neurol. 2013 Feb;20(2):251-8
pubmed: 22900631
Mol Genet Metab. 2001 Dec;74(4):458-75
pubmed: 11749051
Radiographics. 2003 Mar-Apr;23(2):341-58
pubmed: 12640151
Eur J Radiol. 2021 Aug;141:109812
pubmed: 34118766
J Neurol. 2017 Jul;264(7):1334-1342
pubmed: 28503705